Discovery Vanderbilt

Join the next Lab-to-Table conversation, “Beyond Addiction: Therapeutic Developments and Societal Impact” on Jan. 24 at 11:30 a.m. CT. Read More

The Vanderbilt Center for Addiction Research, led by Erin Calipari, advances research to understand how addiction and substance use disorder develops in the brain. VCAR’s goals are to develop new pharmaceutical strategies and to destigmatize addiction as a personal failing. Read More

In just over two years, a Vanderbilt-Neumora collaboration has led to the Phase 1 clinical trial of a treatment for schizophrenia spectrum disorders, which affect 3.7 million adults in the United States. This is the third chemical compound discovered at the Warren Center for Neuroscience Drug Discovery to reach Phase 1 clinical trials.     Read More

Vanderbilt has announced the addition of the Warren Center for Neuroscience Drug Discovery into Discovery Vanderbilt as well as an initiative within the Dare to Grow campaign to inspire philanthropy with a one-to-one match for gifts of $100,000 or more. Read More

The Seeding Success Grant at Vanderbilt University has helped propel ADVISER, an innovative software platform created by David Hyde, assistant professor of computer science, to earning National Science Foundation funding. ADVISER is designed to democratize access to high-end cloud computing, and the new NSF grant applies it to climate change research. Read More

Stronger than at any other time in our history, we are positioned to do more than just meet the challenges of our times. We have what it takes to thrive and lead—to define and become the great university of this century. Read More

A university leadership committee has approved Discovery Vanderbilt investments into three faculty-initiated startups—HeroWear, IDBiologics and Virtuoso Surgical Inc.—as part of its mission from the offices of the chancellor and provost to boost innovation across the university. “These three initial investments will fuel discovery and accelerate the translation of our research into real-world benefits,” Chancellor Daniel... Read More

A university leadership committee has approved Discovery Vanderbilt investments into three faculty-initiated startups—HeroWear, IDBiologics and Virtuoso Surgical Inc.—as part of its mission from the offices of the chancellor and provost to boost innovation across the university. “These three initial investments will fuel discovery and accelerate the translation of our research into real-world benefits,” Chancellor Daniel... Read More

A clinical patient encounter led two Medical Innovators Development Program students to develop a potentially life-saving technology through an industry immersion experience with GE HealthCare. Read More

Class of 2022: Whether giving legal support to survivors of sexual assault, immigrants or inmates on Tennessee’s death row, Emily Burgess is on a mission to be an advocate for those in need. Read More